Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Corvus Pharma Q3 EPS $(0.12) Beats $(0.14) Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:01pm
Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 12.41 percent. This is a 80 percent increase over losses of $(0.60) per share from the same period last year.

Posted In: CRVS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist